[go: up one dir, main page]

GB9928193D0 - Cell treatment method - Google Patents

Cell treatment method

Info

Publication number
GB9928193D0
GB9928193D0 GBGB9928193.3A GB9928193A GB9928193D0 GB 9928193 D0 GB9928193 D0 GB 9928193D0 GB 9928193 A GB9928193 A GB 9928193A GB 9928193 D0 GB9928193 D0 GB 9928193D0
Authority
GB
United Kingdom
Prior art keywords
treatment method
cell treatment
cell
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9928193.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Bristol
Original Assignee
University of Bristol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Bristol filed Critical University of Bristol
Priority to GBGB9928193.3A priority Critical patent/GB9928193D0/en
Publication of GB9928193D0 publication Critical patent/GB9928193D0/en
Priority to AU17166/01A priority patent/AU1716601A/en
Priority to PCT/GB2000/004542 priority patent/WO2001040445A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/22—Immunosuppressive or immunotolerising
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/416—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GBGB9928193.3A 1999-11-29 1999-11-29 Cell treatment method Ceased GB9928193D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9928193.3A GB9928193D0 (en) 1999-11-29 1999-11-29 Cell treatment method
AU17166/01A AU1716601A (en) 1999-11-29 2000-11-29 Cell isolation method
PCT/GB2000/004542 WO2001040445A1 (en) 1999-11-29 2000-11-29 Cell isolation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9928193.3A GB9928193D0 (en) 1999-11-29 1999-11-29 Cell treatment method

Publications (1)

Publication Number Publication Date
GB9928193D0 true GB9928193D0 (en) 2000-01-26

Family

ID=10865360

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9928193.3A Ceased GB9928193D0 (en) 1999-11-29 1999-11-29 Cell treatment method

Country Status (3)

Country Link
AU (1) AU1716601A (en)
GB (1) GB9928193D0 (en)
WO (1) WO2001040445A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE410680T1 (en) 2001-05-26 2008-10-15 One Cell Systems Inc SECRETION OF PROTEINS BY ENCAPSULATED CELLS
ES2343721B1 (en) * 2008-12-19 2011-06-06 Histocell, S.L. CELL TRANSPORTATION SYSTEM.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277635B1 (en) * 1992-03-04 2001-08-21 Schering Corporation Use of interleukin-10 to produce a population of suppressor cells
CA2227327A1 (en) * 1995-07-25 1997-02-13 Celltherapy, Inc. Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
WO1999064560A1 (en) * 1998-06-08 1999-12-16 Basf Aktiengesellschaft Methods for monitoring the stability of protein or cellular product secretion by cells in a fermenter culture

Also Published As

Publication number Publication date
WO2001040445A1 (en) 2001-06-07
AU1716601A (en) 2001-06-12

Similar Documents

Publication Publication Date Title
GB9918031D0 (en) Method
GB9916757D0 (en) Method
GB9928208D0 (en) Method
GB0007871D0 (en) Method
GB9915625D0 (en) Method
GB9928193D0 (en) Cell treatment method
GB9919370D0 (en) Method
GB9928206D0 (en) Method
GB2355455B (en) Method
GB9917130D0 (en) Treating cells
GB9915936D0 (en) Method
GB9920334D0 (en) Method
GB9926435D0 (en) Method
GB0007867D0 (en) Method
GB9707698D0 (en) Cell treatment method
GB9914913D0 (en) Method
GB9921850D0 (en) Method
GB9911938D0 (en) Method
GB9911682D0 (en) Method
GB9913654D0 (en) Method
GB9909799D0 (en) Method
GB9915346D0 (en) Method
GB9908162D0 (en) Method
GB9908160D0 (en) Method
GB9907196D0 (en) Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)